Vascular endothelial growth factor (VEGF165) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma

Microvascular Research

Volumn 57, Issue 2, 1999, Pages 208-210

  Mercie P ^a   Devianne, I ^b   Viallard, J F ^a   Faure, I ^a   Pellegrin, I ^b   Leng, B ^a   Dupon, M ^a   Barbeau, P ^a   Fleury, H ^b   Pellegrin, J L ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN NODULE;

HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032807648     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1998.2129     Document Type: Article

References (11)

1. Brown L. F., Tognazzi K., Dvorak H. F., Harrist T. J. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am. J. Pathol. 148:1996;1065-1074.
2. Cornali E., Zietz C., Benelli R., Weninger W., Masiello L., Breier G., Tschachler E., Albini A., Sturzl M. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol. 149:1996;1851-1869.
3. De Vries C., Escobedo J. A., Ueno H., Houck F., Ferrara N., Williams L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989-991.
4. Dvorak, H. F. Brown, L. F. Detmar, M. Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am. J. Pathol. 146, 1029, 1039.
5. Ferrara N., Henzel W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161:1989;851-858.
6. Kendall R., Wang G., Thomas K. A. Identification of a natural soluble forms of the vascular endothelial growth factor receptor Flt-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226:1996;324-328.
7. Masood R., Cai J., Zheng T., Smith D. L., Naidu Y., Gill P. S. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc. Natl. Acad. Sci. 94:1997;979-984.
8. Nakamura, S. Murakami-Mori, K. Rao, N. Weich, H. A. Rajeev, B. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells, J. Immunol. 158, 4992, 5001.
9. Sakadura S., Kato T., Mashiba K., Mori S., Okamoto T. Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome. Jpn. J. Cancer Res. 87:1996;1143-1152.
10. Senger D., Van de Water L., Brown L., Nagy J., Yeo K. T., Teo T. K., Berse B., Jackman R., Dvorak A., Dvorak H. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metas. Rev. 12:1993;303-324.
11. Thomas K. A., Gimenez-Gallego G. Fibroblast growth factors: Broad spectrum mitogens with potent angiogenic activity. Trends Biochem. Sci. 11:1986;81-84.